A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
Part of paid clinical trials in Litchfield Park, Arizona.
- Sponsor
- Amgen
- Study ID
- NCT05651711
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Rocatinlimab — DRUGRocatinlimab will be administered through a subcutaneous (SC) injection.
- Placebo — OTHERThe matching placebo will be administered through a SC injection.
Study Details
The co-primary objectives of the study are to: * Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD). * Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Eczema Area and Severity Index (EASI).
Key Dates
- Start date
- Dec 14, 2022
- Status verified
- Apr 2025
- Primary completion
- Jun 5, 2024
- Completion
- Aug 27, 2024
Study Design
- Enrollment
- 726 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: RocatinlimabRocatinlimab Dose 1 every 4 weeks (Q4W) for 24 weeks with a loading dose at Week 2.
- Placebo Comparator: PlaceboPlacebo Q4W for 24 weeks with a loading dose at Week 2.
Primary Outcome Measure
Achievement of a Validated Investigator's Global Assessment for Atopic Dermatitis Score of 0 (Clear) or 1 (Almost Clear) with a ≥ 2 Point Reduction From Baseline (vIGA-AD 0/1) at Week 24 [ Time Frame: Baseline and Week 24 ]
Locations (69)
Find similar trials in Litchfield Park, AZ
By condition
By specialty
By research site
Research Solutions of Arizona, PC· Litchfield Park, AZCenter for Dermatology and Plastic Surgery· Scottsdale, AZClinical Trials Institute of Northwest Arkansas· Fayetteville, ARBurke Pharmaceutical Research· Hot Springs, ARVelocity Clinical Research Chula Vista· Chula Vista, CAWest Coast Research LLC· Dublin, CA
Related Studies
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)Recruiting · Regeneron Pharmaceuticals · Boston, Massachusetts
- Skin Microbial Ecology in Atopic DermatitisRecruiting · University of Rochester · Rochester, New York
- Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 PolymorphismRecruiting · Boston Children's Hospital · Boston, Massachusetts
- CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and EffectivenessEnrolling By Invitation · CorEvitas · Waltham, Massachusetts